Gapping down
In reaction to disappointing earnings/guidance:
- HTGM -5%, MU -2.8%
M&A news:
- SLCA -1.3% (to acquire EP Minerals for $750 mln in cash)
Other news:
- PGNX -18.1% (FDA extends review of the New Drug Application for AZEDRA by three months to July 30, 2018)
- AKBA -10.4% (proposes $85 mln public offering of common stock)
- FLL -9.9% (registers direct offering of up to 4,166,667 shares of common stock for gross proceeds of up to $12.5 mln)
- LPTX -9% (commences an underwritten public offering of its common stock)
- OMEX -7.8% (after 100%+ move higher)
- RESN -6.9% (prices offering of 5,714,286 shares of its common stock at $3.50 per share)
- PLUG -2.6% (announces pricing of offering of $100 mln of convertible senior notes)
- SRNE -2% (files for approx 34.2 mln share common stock offering by selling shareholders; files for 1,381,345 share offering by holders pursuant to Scilex Pharmace Stock Purchase Agreement)
- AMAT -1.3% (following MU earnings)
- INTC -1.0% (following MU earnings)
Analyst comments:
- PLCE -3% (downgraded to Underperform from Buy at BofA/Merrill)
- NTNX -1.9% (removed from Conviction Buy List at Goldman)
- BPL -1.0% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
![]()